Sees Q1 adjusted EBITDA $31M-$37M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- EVH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Evolent Health Strengthens Board with Strategic Changes
- Evolent Health price target lowered to $14 from $36 at TD Cowen
- Evolent Health price target lowered to $12 from $18 at JMP Securities
- Evolent Health price target lowered to $16 from $23 at Canaccord